HIV Vaccine :: Merck’s HIV vaccine not effective to stop HIV & AIDS
International drug company Merck has halted trials on an HIV vaccine that was regarded as one of the most promising in the fight against Aids.
International drug company Merck has halted trials on an HIV vaccine that was regarded as one of the most promising in the fight against Aids.
Vaccination in a phase II clinical trial of Merck & Co., Inc.’s investigational HIV vaccine (V520) is being discontinued because the vaccine was not effective.
Beijing registered 563 new cases of HIV/AIDS in the first half of this year, up 50 per cent from the same period last year, mostly through needle sharing and sex, a health official said here.
Tibotec Pharmaceuticals Ltd. announced that the New Drug Application (NDA) for TMC125 (etravirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), has been accepted for priority review by the United States Food and Drug Administration (FDA).
In the year since it was established to provide medicines for HIV/AIDS, malaria and tuberculosis to the poorest people of developing countries, the United Nations-backed international drug purchase facility UNITAID has managed to reduce the price of HIV treatments for children by almost 40 per cent.
In the year since it was established, the international drug purchase facility UNITAID has managed to reduce the price of HIV treatments for children by almost 40%, and those for second-line antiretroviral (ARV) drugs by between 25% and 50%.
Giving a daily antiretroviral pill to people to prevent HIV could profoundly slow the spread of the infection in sub-Saharan Africa, where it is a full-blown epidemic, University of Pittsburgh School of Medicine researchers report.
Health & Govt. officials in Peru have closed 40 of the country”s blood banks after at least four people were infected with HIV from blood transfusions in a public hospital.
HIV infection is on the rise among young men who have sex with men (MSM) in New York City, according to preliminary data from the Health Department. New HIV diagnoses among MSM under age 30 have increased by 33% during the past six years, the agency reported today, from 374 in 2001 to almost 500 in 2006.
HIV patients with declining platelet counts appear to be at increased risk for HIV?associated dementia, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.